These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21530542)

  • 41. An interpretation of positional displacement of the helix12 in nuclear receptors: preexistent swing-up motion triggered by ligand binding.
    Watanabe C; Watanabe H; Tanaka S
    Biochim Biophys Acta; 2010 Sep; 1804(9):1832-40. PubMed ID: 20601221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ligand Pathways in Nuclear Receptors.
    Fischer A; Smieško M
    J Chem Inf Model; 2019 Jul; 59(7):3100-3109. PubMed ID: 31246455
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple molecular dynamics simulations of human LOX-1 and Trp150Ala mutant reveal the structural determinants causing the full deactivation of the receptor.
    Iacovelli F; Tucci FG; Macari G; Falconi M
    Proteins; 2017 Oct; 85(10):1902-1912. PubMed ID: 28657156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural change of retinoic-acid receptor-related orphan receptor induced by binding of inverse-agonist: Molecular dynamics and
    Suzuki S; Nakamura T; Saito R; Terauchi Y; Kawai K; Takimoto-Kamimura M; Kurita N
    Comput Struct Biotechnol J; 2020; 18():1676-1685. PubMed ID: 32670507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural insights on the effects of mutation of a charged binding pocket residue on phosphopeptide binding to 14-3-3ζ protein.
    T S S; Dalvi S; Venkatraman P; Vemparala S
    Proteins; 2022 May; 90(5):1179-1189. PubMed ID: 35006623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutantelec: An In Silico mutation simulation platform for comparative electrostatic potential profiling of proteins.
    Valdebenito-Maturana B; Reyes-Suarez JA; Henriquez J; Holmes DS; Quatrini R; Pohl E; Arenas-Salinas M
    J Comput Chem; 2017 Mar; 38(7):467-474. PubMed ID: 28114729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-specific basicities regulate molecular recognition in receptor binding: in silico docking of thyroid hormones.
    Tóth G; Baska F; Schretner A; Rácz A; Noszál B
    Eur Biophys J; 2013 Sep; 42(9):721-30. PubMed ID: 23907234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Models for the binding of amiodarone to the thyroid hormone receptor.
    Chalmers DK; Munro SL; Iskander MN; Craik DJ
    J Comput Aided Mol Des; 1992 Feb; 6(1):19-31. PubMed ID: 1583537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamics Insights Into the Gain of Flexibility by Helix-12 in ESR1 as a Mechanism of Resistance to Drugs in Breast Cancer Cell Lines.
    Khan A; Ashfaq-Ur-Rehman ; Junaid M; Li CD; Saleem S; Humayun F; Shamas S; Ali SS; Babar Z; Wei DQ
    Front Mol Biosci; 2019; 6():159. PubMed ID: 32039233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Erratum: Recognition of fold- and function-specific sites in the ligand-binding domain of the thyroid hormone receptor-like family.
    Frontiers Production Office
    Front Endocrinol (Lausanne); 2023; 14():1175369. PubMed ID: 36967784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular Dynamic Simulation To Reveal the Mechanism Underlying MGL-3196 Resistance to Thyroxine Receptor Beta.
    Lu Y; Chen C; Zhuang D; Qian L
    ACS Omega; 2024 May; 9(19):20957-20965. PubMed ID: 38764645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid hormone receptors and resistance to thyroid hormone disorders.
    Ortiga-Carvalho TM; Sidhaye AR; Wondisford FE
    Nat Rev Endocrinol; 2014 Oct; 10(10):582-91. PubMed ID: 25135573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a new hormone-binding site on the surface of thyroid hormone receptor.
    Souza PC; Puhl AC; Martínez L; Aparício R; Nascimento AS; Figueira AC; Nguyen P; Webb P; Skaf MS; Polikarpov I
    Mol Endocrinol; 2014 Apr; 28(4):534-45. PubMed ID: 24552590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oroxylin A inhibits hemolysis via hindering the self-assembly of α-hemolysin heptameric transmembrane pore.
    Dong J; Qiu J; Zhang Y; Lu C; Dai X; Wang J; Li H; Wang X; Tan W; Luo M; Niu X; Deng X
    PLoS Comput Biol; 2013; 9(1):e1002869. PubMed ID: 23349625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of thyroid hormone action.
    Brent GA
    J Clin Invest; 2012 Sep; 122(9):3035-43. PubMed ID: 22945636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Helix 12 dynamics and thyroid hormone receptor activity: experimental and molecular dynamics studies of Ile280 mutants.
    Souza PC; Barra GB; Velasco LF; Ribeiro IC; Simeoni LA; Togashi M; Webb P; Neves FA; Skaf MS; Martínez L; Polikarpov I
    J Mol Biol; 2011 Oct; 412(5):882-93. PubMed ID: 21530542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular dynamics simulations for human CAR inverse agonists.
    Jyrkkärinne J; Küblbeck J; Pulkkinen J; Honkakoski P; Laatikainen R; Poso A; Laitinen T
    J Chem Inf Model; 2012 Feb; 52(2):457-64. PubMed ID: 22233089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.